Insights into inflammation and influenza.
Simmons
Cameron
C
Hospital for Tropical Diseases, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Farrar
Jeremy
J
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D053124:Influenza A Virus, H5N1 Subtype / Q000187:drug effects / Q000502:physiology*; D007251:Influenza, Human / Q000188:drug therapy; D019804:Mesalamine / Q000627:therapeutic use; D051379:Mice; D009976:Orthomyxoviridae Infections / Q000188:drug therapy* / Q000821:virology; D011720:Pyrazoles / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D053243:Zanamivir / Q000627:therapeutic use
D000998:Antiviral Agents; D016861:Cyclooxygenase Inhibitors; D007155:Immunologic Factors; D011720:Pyrazoles; D013449:Sulfonamides; D019804:Mesalamine; D000068579:Celecoxib; D053243:Zanamivir